SYNERGISTIC COMBINATION TREATMENT OF PROSTATE CANCER USING CD46- TARGETED ANTIBODY-DRUG CONJUGATE AND RADIOIMMUNOTHERAPY

Regents Of The University Of California, San Francisco, The

Investigators